Details of the Drug

General Information of Drug (ID: DMNDZMB)

Drug Name

A-101

Synonyms

A-101; AC1L4MEL; AC1Q1Z6J; N-Phenylacetoaminomethylene-DL-p-nitrophenylalanine; 4-nitro-n-{[(phenylacetyl)amino]methyl}-l-phenylalanine; MALANEHOOMRDSZ-INIZCTEOSA-N; 70172-42-8; DL-Phenylalanine, 4-nitro-N-(((phenylacetyl)amino)methyl)-; (S)-alpha-[[[(Phenylacetyl)amino]methyl]amino]-p-nitrobenzenepropanoic acid; (2S)-3-(4-nitrophenyl)-2-[[(2-phenylacetyl)amino]methylamino]propanoic acid

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H19N3O5
Canonical SMILES: C1=CC=C(C=C1)CC(=O)NCNC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)O
InChI: 1S/C18H19N3O5/c22-17(11-13-4-2-1-3-5-13)20-12-19-16(18(23)24)10-14-6-8-15(9-7-14)21(25)26/h1-9,16,19H,10-12H2,(H,20,22)(H,23,24)/t16-/m0/s1
InChIKey: MALANEHOOMRDSZ-INIZCTEOSA-N

Cross-matching ID

PubChem CID: 188218
CAS Number: 70172-42-8
TTD ID: D04QUG

References

1	ClinicalTrials.gov (NCT02160626) Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis. U.S. National Institutes of Health.